Bank of New York Mellon Corp Sells 343,581 Shares of Oscar Health, Inc. (NYSE:OSCR)

Bank of New York Mellon Corp lessened its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 25.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,031,827 shares of the company's stock after selling 343,581 shares during the period. Bank of New York Mellon Corp owned about 0.41% of Oscar Health worth $13,527,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Summit Investment Advisors Inc. increased its stake in shares of Oscar Health by 5.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after purchasing an additional 1,141 shares in the last quarter. Oppenheimer & Co. Inc. raised its holdings in Oscar Health by 4.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock valued at $372,000 after buying an additional 1,250 shares during the last quarter. Xponance Inc. raised its holdings in Oscar Health by 12.9% during the 4th quarter. Xponance Inc. now owns 14,394 shares of the company's stock valued at $193,000 after buying an additional 1,649 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Oscar Health by 15.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 13,862 shares of the company's stock valued at $186,000 after buying an additional 1,834 shares during the last quarter. Finally, California State Teachers Retirement System increased its stake in shares of Oscar Health by 1.2% in the 4th quarter. California State Teachers Retirement System now owns 156,901 shares of the company's stock worth $2,109,000 after acquiring an additional 1,846 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director owned 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 25.11% of the stock is currently owned by insiders.

Oscar Health Price Performance

Shares of OSCR traded up $0.17 during midday trading on Monday, hitting $13.59. The company's stock had a trading volume of 47,561,996 shares, compared to its average volume of 7,950,369. The company's fifty day simple moving average is $16.21 and its two-hundred day simple moving average is $14.92. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The stock has a market capitalization of $3.46 billion, a price-to-earnings ratio of 48.55 and a beta of 1.90. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business's revenue was up 42.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.62 earnings per share. As a group, equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Barclays started coverage on shares of Oscar Health in a research report on Wednesday, July 2nd. They issued an "underweight" rating and a $17.00 price objective on the stock. UBS Group reiterated a "sell" rating and issued a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Piper Sandler cut shares of Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price target on the stock. in a research note on Monday, July 14th. Wells Fargo & Company downgraded shares of Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their target price for the stock from $16.00 to $10.00 in a research report on Friday, July 11th. Finally, Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Five analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat.com, Oscar Health presently has a consensus rating of "Reduce" and a consensus target price of $12.92.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.